PILOTTI, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 748
EU - Europa 562
AS - Asia 235
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.551
Nazione #
US - Stati Uniti d'America 730
CN - Cina 145
IE - Irlanda 97
FI - Finlandia 88
UA - Ucraina 86
SE - Svezia 83
SG - Singapore 83
FR - Francia 75
DE - Germania 50
GB - Regno Unito 37
IT - Italia 23
CA - Canada 18
BE - Belgio 15
TR - Turchia 6
CI - Costa d'Avorio 3
LT - Lituania 3
AT - Austria 2
EU - Europa 2
CZ - Repubblica Ceca 1
ES - Italia 1
IN - India 1
MA - Marocco 1
NL - Olanda 1
Totale 1.551
Città #
Chandler 124
Dublin 97
Jacksonville 90
Dearborn 73
Ann Arbor 69
Singapore 67
Santa Clara 50
Boardman 37
Shanghai 30
Ashburn 29
Nanjing 26
Helsinki 22
Princeton 19
Wilmington 19
Woodbridge 19
Beijing 15
Brussels 15
San Mateo 15
Toronto 13
Shenyang 12
Hebei 10
Seattle 9
New York 8
Falkenstein 7
Jinan 7
Changsha 6
Izmir 6
Nanchang 6
Auburn Hills 5
Hefei 5
Parma 5
Bremen 4
Abidjan 3
Guangzhou 3
Los Angeles 3
Norwalk 3
Centuripe 2
Düsseldorf 2
Hangzhou 2
Isorella 2
Jiaxing 2
Kunming 2
London 2
Malo 2
Ningbo 2
Ottawa 2
Palermo 2
Redwood City 2
Vienna 2
Xian 2
Brno 1
Chengdu 1
Corner Brook 1
Des Moines 1
Edinburgh 1
Fremont 1
Leeds 1
Mantova 1
Monmouth Junction 1
Montreal 1
Montréal 1
Odesa 1
Padova 1
Palma De Mallorca 1
Pune 1
Quzhou 1
Taiyuan 1
Taizhou 1
Tianjin 1
Zhengzhou 1
Totale 979
Nome #
Biological insight into the mechanism of action of thiosemicarbazone complexes. 128
Copper(II) and Cobalt(III) Pyridoxal Thiosemicarbazone Complexes with Nitroprusside as Counterion: Syntheses, Electronic Properties, and Antileukemic Activity 114
The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2 102
Striking changes of miRNAs expression in CD4+ T lymphocytes occurred even in the absence of an established HIV-1 infection. 88
THIOSEMICARBAZONES DERIVATIVES (TSCD) EFFECTS ON HIV, HTLV-1 AND HTLV-2 INFECTED CELLS 88
La coinfezione HIV-1/HTLV-2 è associata ad un rallentamento della progressione AIDS 85
Antiretroviral Activity of Thiosemicarbazone Metal Complexes 81
HTLV-II influence on AIDS progression and changes in response to antiretroviral therapy in Italian IDUs coinfected with HIV-1 79
HTLV-II infection exerts a protective role against AIDS progression in IDUs coinfected with HIV-1 79
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of CCL3L1 78
HTLV-2 influence on pathways regulating proliferation and death in B cell line BJAB 77
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 76
Screening of HIV-1 Isolates By Reverse Heteroduplex Mobility Assay and Identification of Non-B Subtypes in Italy 75
Delayed progression to aids in HTLV-2/HIV-1 coinfected intravenous drug users 74
Azione concertata ELVIS: espressione selettiva della chemochina CCL3L1 in soggetti LTNP co-infettati da HIV-1 e HTLV-2 71
Inibizione della replicazione virale di HIV-1 e HTLV-2 da parte di CIITA, il regolatore trascrizionale dell'espressione dell'HLA-II 69
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of the CCL3/MIP-1alpha isoform L1/LD78beta 68
Un mimotopo sintetico killer, attivo nei confronti di patogeni opportunisti correlati ad AIDS inibisce l'infezione esogena ed endogena di HIV 63
The MHC Class II Transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection 62
Totale 1.557
Categoria #
all - tutte 5.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020186 0 0 0 0 0 74 45 6 28 8 5 20
2020/2021181 2 23 22 3 21 3 20 4 46 9 25 3
2021/2022104 2 2 1 2 3 2 10 18 5 9 26 24
2022/2023407 42 42 34 29 43 54 1 30 114 2 10 6
2023/2024127 5 15 3 4 11 24 11 16 6 4 8 20
2024/2025185 3 21 26 36 37 62 0 0 0 0 0 0
Totale 1.557